Provided by Tiger Trade Technology Pte. Ltd.

Moleculin Biotech

2.39
-0.0200-0.83%
Pre-market: 2.35-0.0400-1.67%04:59 EST
Volume:72.14K
Turnover:175.13K
Market Cap:7.36M
PE:-0.04
High:2.49
Open:2.45
Low:2.38
Close:2.41
52wk High:33.00
52wk Low:2.25
Shares:3.08M
Float Shares:3.03M
Volume Ratio:0.25
T/O Rate:2.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-55.8792
EPS(LYR):-158.0236
ROE:-503.80%
ROA:-69.18%
PB:-0.27
PE(LYR):-0.02

Loading ...

BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance

Reuters
·
Jan 07

Moleculin Biotech Inc - Regains Nasdaq Listing Compliance - SEC Filing

THOMSON REUTERS
·
Jan 07

Moleculin Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Dec 20, 2025

Moleculin Reports Positive Phase 1 Results for WP1066 in Pediatric Brain Tumors

Reuters
·
Dec 17, 2025

Moleculin Biotech Inc - WP1066 Found Safe and Effective, Warranting Phase 2 Trial

THOMSON REUTERS
·
Dec 17, 2025

Moleculin Announces Positive Results From Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

THOMSON REUTERS
·
Dec 17, 2025

Moleculin Biotech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 11, 2025

Moleculin Biotech Raises $6.8 Million Through Warrant Exercises

Reuters
·
Dec 10, 2025

Moleculin Biotech Nears First Unblinding in Pivotal Phase 3 AML Trial

Reuters
·
Dec 09, 2025

Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “Miracle” Phase 3 Aml Trial on Pace for Q1 2026

THOMSON REUTERS
·
Dec 09, 2025

Moleculin Biotech Partners with CIC biomaGUNE to Study Annamycin for Brain Tumors

Reuters
·
Dec 08, 2025

Moleculin Announces New Annamycin Collaboration in Brain Tumors

THOMSON REUTERS
·
Dec 08, 2025

Moleculin Biotech Inc - Enters Research Agreement With Cic Biomagune

THOMSON REUTERS
·
Dec 08, 2025

Moleculin Biotech trading halted, news pending

TIPRANKS
·
Nov 29, 2025

Moleculin Biotech Enacts 1-for-25 Reverse Stock Split

Reuters
·
Nov 29, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Nucor, Natgas companies, health insurers

Reuters
·
Nov 27, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Robinhood Markets, Oracle, Grindr

Reuters
·
Nov 26, 2025

BUZZ-Moleculin Biotech falls after reverse stock split move

Reuters
·
Nov 26, 2025

Moleculin Biotech Inc - to Effect 1-for-25 Reverse Stock Split December 1

THOMSON REUTERS
·
Nov 26, 2025

Moleculin Biotech Appeals Nasdaq Delisting Decision

TIPRANKS
·
Nov 22, 2025